🇩🇪 Poteligeo in Germany

Poteligeo (MOGAMULIZUMAB) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Poteligeo
  • Status: approved

Poteligeo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is Poteligeo approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for Poteligeo in Germany?

Kyowa Kirin is the originator. The local marketing authorisation holder may differ — check the official source linked above.